Super Bet richtet sein Angebot klar auf Spieler in Deutschland aus und setzt dabei konsequent auf Mobile First. Für Einsteiger ist wichtig zu verstehen, wie die App‑Mechanik, die getrennten Wallets für Sportwetten und Slots, sowie die deutschen Regulierungen den Alltag prägen. Dieser Leitfaden erklärt Praxisdetails, typische Missverständnisse rund um Zahlungen und RTP, technische und regulatorische
Carlson Caspers
Website:
https://www.carlsoncaspers.com/
Latest from Carlson Caspers - Page 5
Mrgreen review: how the brand performs and what Canadian players should know
Mrgreen is a long-standing international casino brand with a polished presentation and a multi-provider game lobby. For Canadians deciding whether the site fits their expectations, the practical questions are licensing, payment options (Interac matters here), game mix, mobile experience, and how the operator has handled regulatory issues in the past. This review breaks those topics…
Spin reseña y reputación del sitio (CL)
Spin es una marca con trayectoria que llegó al mercado online como evolución de Spin Palace; para jugadores en Chile representa una opción clásica de casino con énfasis en tragamonedas de catálogo tradicional y pozos progresivos. En esta reseña práctica explico cómo funciona la plataforma desde la perspectiva de un usuario chileno principiante: métodos de…
Vavada: Spielerschutz und verantwortungsvolles Spielen in Deutschland (DE)
Vavada ist für viele Spieler aus Deutschland eine bekannte Offshore-Option: große Spielauswahl, hohe Limits und schnelle Krypto-Auszahlungen. Gleichzeitig bringt genau diese Struktur spezifische Risiken und Mechaniken mit sich, die insbesondere Einsteiger verstehen sollten, bevor sie ein Konto eröffnen oder einzahlen. Dieser Text erklärt praxisnah, wie Spielerschutz, Verifizierung, Auszahlungen und die rechtlichen Grenzen bei Vavada funktionieren…
Validation Check 2026-05-05 09:23:46
This is a validation post. Time: 2026-05-05 09:23:46
The post Validation Check 2026-05-05 09:23:46 appeared first on .
IRS Treatment of Litigation Costs in ANDA Cases Affirmed
The Third Circuit Court of Appeals affirmed on July 27, 2023, that infringement-suit defense costs for ANDA filers who file Paragraph IV certifications are deductible legal expenses, not capital expenditures to obtain FDA approval. The Court of Appeals noted that legal defense costs for ANDA filers do not “facilitate” obtaining an intangible asset because “ultimate…
Supreme Court Upholds Federal Circuit’s Full-Scope Enablement Test in Amgen Inc. v. Sanofi
[1] See our previous post on this case for a description of the arguments made on either side of the issue.
Recently, a unanimous Supreme Court issued its ruling in Amgen Inc. v. Sanofi, holding that Amgen’s challenged patents ran afoul of Section 112’s enablement requirement.[1] Writing for the Court, Justice Gorsuch focused on…
Recitation of Common Functional Groups for Genus Claims Fails Written Description Requirement
In an opinion issued on March 6, 2023, the Federal Circuit affirmed the PTAB’s holding of unpatentability because the applications from which the patent claimed priority from lacked sufficient written description under 35 U.S.C. § 112. Regents of University of MN v. Gilead Sciences, Inc., No. 2021-2168 (March 6, 2021). Because the patent could…
Federal Circuit Upholds Decision to Delist System Patent from the Orange Book
Recently, the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware granting a motion for an injunction to delist Jazz Pharmaceuticals, Inc.’s (“Jazz”) REMS patent from the Orange Book, as the patent covers neither the drug itself nor a method of using it. Jazz Pharms., Inc., v. Avadel CNS…
Amici Weigh in on Enablement in Amgen Inc. v. Sanofi
On Friday, February 10, 2023, the latest round of amicus briefs in Amgen Inc. v. Sanofi poured in. The case, set to be argued on March 27 before the U.S. Supreme Court, asks the Court to wrestle with the enablement requirement of Section 112 of the Patent Act. Specifically, the Court has been asked to…